This HTML5 document contains 143 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1177/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35132987
rdf:type
wikibase:Item
schema:description
২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ سائنسی مضمون scienca artikolo wissenschaftlicher Artikel 2003年论文 artículu científicu espublizáu en 2003 vetenskaplig artikel 2003年論文 artykuł naukowy videnskabelig artikel (udgivet 2003) научни чланак мақолаи илмӣ artikull shkencor บทความทางวิทยาศาสตร์ articolo scientifico научна статия artigo científico (publicado na 2003) tudományos cikk bilimsel makale мақолаи илмӣ 2003年论文 επιστημονικό άρθρο artigo científico article scientific 2003年論文 наукова стаття, опублікована у квітні 2003 مقالهٔ علمی 2003年論文 2003年論文 vitenskapelig artikkel article scientifique (publié 2003) 2003年の論文 naučni članak article científic artículo científico publicado en 2003 wetenschappelijk artikel scientific article mokslinis straipsnis 2003年论文 bài báo khoa học 2003年論文 vitskapeleg artikkel teaduslik artikkel 2003년 논문 مقالة علمية 2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած 2003年论文 2003年论文 tieteellinen artikkeli 2003 թվականի ապրիլին հրատարակված գիտական հոդված artikulong pang-agham научни чланак articol științific научная статья 2003 nî lūn-bûn מאמר מדעי სამეცნიერო სტატია vědecký článek 2003年论文 vedecký článok artigo científico (publicado na 2003)
p:P577
wds:Q35132987-7C9938DD-5FD1-4CD2-85AB-2CD3FC4D7ED4
wdt:P577
2003-04-01T00:00:00Z
p:P2860
wds:Q35132987-5375F955-944B-40C1-A8BE-4E087F5B7F17 wds:Q35132987-54289FE8-0197-486C-8FA9-0CFE61922FC0 wds:Q35132987-57B32EA7-500B-472D-BF35-BD5E0DCD256C wds:Q35132987-678CF78A-4956-48CA-8C3E-9338FE895180 wds:Q35132987-2059384F-9CBC-4CBD-B9E6-8AF68729922D wds:Q35132987-323D0F48-847D-41AF-9527-95363CCA8CCE wds:Q35132987-9CF5442D-DFD8-43CF-84F4-58906A203E9F wds:Q35132987-A0989E29-C6D1-4A72-A51E-74508ACFE908 wds:Q35132987-AA940D7A-B4F0-4075-BB49-868DB83B158A wds:Q35132987-AFF40B28-964C-48F5-A804-41A9F4123F00 wds:Q35132987-CE677965-7F05-4F50-876C-7F397D75F11C wds:Q35132987-D63358FE-0A1D-4741-9051-06A8ED574680 wds:Q35132987-85F061AB-5D90-4A2C-A573-2256AA7350BF wds:Q35132987-8D8C4B09-0FCF-4BBC-8D73-96C7CDAB318B wds:Q35132987-9182F806-17DC-402A-AFF0-E90BFBA4B16C wds:Q35132987-EDAA9B50-8F50-404C-84E1-0076CDC0421A
wdt:P2860
wd:Q41759923 wd:Q33865133 wd:Q53895028 wd:Q53913823 wd:Q34082054 wd:Q33866673 wd:Q33328672 wd:Q48723958 wd:Q35572162 wd:Q42660595 wd:Q34484322 wd:Q52034189 wd:Q34489244 wd:Q53913826 wd:Q33873526 wd:Q43542347
p:P2093
wds:Q35132987-59F88474-B8DA-4572-83F9-EEE21CBE7774 wds:Q35132987-51532A9B-B022-4066-B5CD-C4C6DB9768D3 wds:Q35132987-3987ACCE-D764-4FDC-86DA-17C27A378727 wds:Q35132987-0BCA3479-8819-4292-92DA-314536578B27 wds:Q35132987-D670B0E8-EEF5-4050-84EB-599D98A76B63 wds:Q35132987-D8B2064C-1E3D-4BE7-835F-30313DBC6A6F wds:Q35132987-71AB677E-BBB4-4D42-9FEF-E5F3445B1EAF
wdt:P2093
Sara Kivity Rachel Straussberg Uri Kramer Bruria Ben-Zeev Hadassah Goldberg-Stern Nathan Brand Itai Berger
rdfs:label
Clinical experience with open-label topiramate use in infants younger than 2 years of age. Clinical experience with open-label topiramate use in infants younger than 2 years of age. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
skos:prefLabel
Clinical experience with open-label topiramate use in infants younger than 2 years of age. Clinical experience with open-label topiramate use in infants younger than 2 years of age. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
schema:name
Clinical experience with open-label topiramate use in infants younger than 2 years of age. Clinical experience with open-label topiramate use in infants younger than 2 years of age. Clinical experience with open-label topiramate use in infants younger than 2 years of age.
p:P50
wds:Q35132987-00AB78F1-D2A3-4DBD-89A5-68D388827C74 wds:Q35132987-803E6028-9762-4DFB-A968-5A482DC8522D
wdt:P50
wd:Q43138332 wd:Q47499256
p:P1476
wds:Q35132987-BEC63D5C-F3FD-419F-8656-454E1D131B67
wdt:P1476
Clinical experience with open-label topiramate use in infants younger than 2 years of age.
p:P304
wds:Q35132987-443BA994-D74D-42B4-B2E7-6D04F630B87B
wdt:P304
258-262
p:P31
wds:Q35132987-951B661A-F3AE-43AE-AC71-63125AF7F683
wdt:P31
wd:Q13442814
p:P698
wds:Q35132987-5840CC08-54D3-4D20-B9CE-55E9FD0DE8B1
wdtn:P698
n12:12760428
wdt:P698
12760428
p:P1433
wds:Q35132987-8DD4D369-95DF-429C-B4EA-83902386CEAC
wdt:P1433
wd:Q6294935
p:P433
wds:Q35132987-155B7559-90A4-4E64-B132-1FAEE632C8B1
p:P478
wds:Q35132987-49D4B8C7-B874-40C0-B6F6-78F135DBE661
wdt:P433
4
wdt:P478
18
p:P356
wds:Q35132987-7D8853DE-7850-4294-A6B1-CF78FD06AF06
wdtn:P356
n10:08830738030180040901
wdt:P356
10.1177/08830738030180040901
p:P5875
wds:Q35132987-5E4A84E1-BAB0-4219-9264-258F59D1E0D4
wdt:P5875
10749711